These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34908012)

  • 21. Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly.
    Eroğlu İ; Iremli BG; Idilman IS; Yuce D; Lay I; Akata D; Erbas T
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e119-e129. PubMed ID: 37590020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    Satapathy SK; Gonzalez HC; Vanatta J; Dyer A; Angel W; Nouer SS; Kocak M; Kedia SK; Jiang Y; Clark I; Yadak N; Nezakagtoo N; Helmick R; Horton P; Campos L; Agbim U; Maliakkal B; Maluf D; Nair S; Halford HH; Eason JD
    PLoS One; 2020; 15(5):e0232006. PubMed ID: 32407331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
    Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease.
    Choi SJ; Kim SM; Kim YS; Kwon OS; Shin SK; Kim KK; Lee K; Park IB; Choi CS; Chung DH; Jung J; Paek M; Lee DH
    Diabetes Metab J; 2021 Sep; 45(5):739-752. PubMed ID: 33108854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
    Lee HA; Kim SS; Choi JY; Seo YS; Park BJ; Sim KC; Kim SU
    Abdom Radiol (NY); 2022 Nov; 47(11):3733-3745. PubMed ID: 35962809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
    Kim BK; Bernstein N; Huang DQ; Tamaki N; Imajo K; Yoneda M; Sutter N; Jung J; Nguyen K; Nguyen L; Le T; Madamba E; Richards L; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
    Aliment Pharmacol Ther; 2023 Jul; 58(2):229-237. PubMed ID: 37269117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique.
    Armstrong T; Ly KV; Murthy S; Ghahremani S; Kim GHJ; Calkins KL; Wu HH
    Pediatr Radiol; 2018 Jul; 48(7):941-953. PubMed ID: 29728744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis.
    Noureddin M; Truong E; Gornbein JA; Saouaf R; Guindi M; Todo T; Noureddin N; Yang JD; Harrison SA; Alkhouri N
    J Hepatol; 2022 Apr; 76(4):781-787. PubMed ID: 34798176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.
    Wang JH; Ou HY; Yen YH; Hung CH; Lu SN
    Liver Int; 2023 Sep; 43(9):1901-1908. PubMed ID: 37249034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity.
    Yang L; Lin Y; Zhu YF; Zhu YY; Liang ZM; Wu GS
    Pediatr Obes; 2022 Jun; 17(6):e12893. PubMed ID: 35092183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study.
    Eroğlu İ; Iremli BG; Erkoc A; Idilman IS; Yuce D; Kutukcu EC; Akata D; Erbas T
    J Clin Densitom; 2024; 27(2):101479. PubMed ID: 38447349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
    Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
    Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.
    Chen J; Martin-Mateos R; Li J; Yin Z; Chen J; Lu X; Glaser KJ; Mounajjed T; Yashiro H; Siegelman J; Winkelmann CT; Wang J; Ehman RL; Shah VH; Yin M
    Alcohol Clin Exp Res; 2021 Oct; 45(10):2103-2117. PubMed ID: 34486129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD.
    Nogami A; Yoneda M; Iwaki M; Kobayashi T; Kessoku T; Honda Y; Ogawa Y; Imajo K; Higurashi T; Hosono K; Kirikoshi H; Saito S; Nakajima A
    Sci Rep; 2022 Dec; 12(1):21925. PubMed ID: 36535977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.
    Schwimmer JB; Middleton MS; Behling C; Newton KP; Awai HI; Paiz MN; Lam J; Hooker JC; Hamilton G; Fontanesi J; Sirlin CB
    Hepatology; 2015 Jun; 61(6):1887-95. PubMed ID: 25529941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
    Suzuki Y; Maekawa S; Yamashita K; Osawa L; Komiyama Y; Nakakuki N; Takada H; Muraoka M; Sato M; Takano S; Fukasawa M; Yamaguchi T; Funayama S; Morisaka H; Onishi H; Enomoto N
    J Gastroenterol Hepatol; 2023 Jun; 38(6):921-929. PubMed ID: 36811251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.